A new paradigm has emerged for osteogenesis imperfecta as a collagen-related disorder.
The more prevalent autosomal dominant forms of osteogenesis imperfecta are caused by …

Osteogenesis imperfecta is a genetic disorder characterized by low bone mass, decreased
bone strength, increased bone fragility, and shortened stature. Autosomal dominant …

Osteogenesis imperfecta (OI) is the most prevalent heritable bone fragility disorder in
children. It has been known for three decades that the majority of individuals with OI have …

This article reviews the manifestations and risk factors associated with osteoporosis in
childhood, the definition of osteoporosis and recommendations for monitoring and …

Background Osteoporosis incidence in children is increasing due to the increased survival
rate of patients suffering from chronic diseases and the increased use of drugs that can …

Background Children with osteogenesis imperfecta are often treated with intravenous
bisphosphonates. We aimed to assess the safety and efficacy of risedronate, an orally …

abstract Context: Information on the use of oral bisphosphonate agents to treat pediatric
osteogenesis imperfecta (OI) is limited. Objective: The objective of the investigation was to …

Cyclical intravenous bisphosphonate therapy is widely used to treat children with
osteogenesis imperfecta (OI), but little is known about long‐term treatment outcomes. We …

Osteogenesis imperfecta (OI) is the most common bone genetic disorder and it is
characterized by bone brittleness and various degrees of growth disorder. Clinical severity …

Osteoporosis is a condition of increased bone fragility associated with fractures. Apart from
primary genetic osteoporotic conditions, secondary osteoporosis in children is being …